PharmaCyte Biotech’s Cancer and Diabetes Treatments Airing Nationwide on Discovery Channel

PharmaCyte Story to Reach More Than 96 Million U.S. Households on June 30

SILVER SPRING, Md., June 29, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that its technology and treatments will be featured on the Discovery Channel and ION Network tomorrow morning, June 30, 2015, from 7:00-7:30 a.m. EDT and PDT, except on DISH Network which airs using the EDT time zone. PharmaCyte Biotech's story will air on Discovery Channel and ION Network's news magazine series "NewsWatch," a source for breaking consumer, technology, travel, health and entertainment news since 1990.
 

NewsWatch, based in the Washington, DC area, airs nationwide in the U.S. and can be seen in virtually every market throughout the country. Each edition of NewsWatch reaches more than 96 million U.S....

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://www.nasdaq.com/press-release/pharmacyte-biotechs-cancer-and-diabetes-treatments-airing-nationwide-on-discovery-channel-20150629-00382